Somatostatin analog (octreotide) and sirolimus immunosuppressive therapy in the treatment of chyloperitoneum and chylothorax in newborns and infants

Somatostatin analog (octreotide) and sirolimus immunosuppressive therapy in the treatment of chyloperitoneum and chylothorax in newborns and infants

Background: Chyloperitoneum (CP) and chylothorax (CT) are rare conditions that have a high mortality rate and unclear treatment options. Their incidence in neonates ranges from 1 in 20000 to 1 in 187000 live births. This study aims to evaluate the effectiveness of synthetic somatostatin analog (oct...

Full description

Bibliographic Details
Main Authors: Aleksandra Gurskaya, Mariya Sulavko, Ekaterina Ekimovskaya, Rimir Bayazitov, Oleg Nakovkin, Inna Karnuta, Anna Klepikova, Dinara Akhmedova, Ruslan Hagurov, Garik Sagoyan, Yelena Dyakonova, Andrey Fisenko
Format: Article
Language:English
Published: EL-Med-Pub 2024-01-01
Series:Journal of Neonatal Surgery
Subjects:
Chyloperitoneum
Chylothorax
Octreotide
Sirolimus
Newborns
Online Access:https://www.jneonatalsurg.com/ojs/index.php/jns/article/view/1240

Internet

https://www.jneonatalsurg.com/ojs/index.php/jns/article/view/1240

Similar Items